Swedish Orphan Biovitrum, also known as Sobi, has entered into a definitive agreement to acquire San Diego, USA-based biotech ...
On December 12, 2025, the US Food and Drug Administration approved Johnson & Johnson subsidiary Janssen Biotech’s Akeega (niraparib and abiraterone acetate with prednisone for adults with deleterious ...
Swedish rare disease specialist Hansa Biopharma announced a reorganization of its European and International Commercial and ...
Japan’s Tanabe Pharma, formerly known as Mitsubishi Tanabe and now owned by Bain Capital, has obtained approval from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback